Determinants of uptake of maternity incentives by women who had a live birth one year prior to the survey, NDHS 2022. حسب Resham B. Khatri (10949429)

Determinant of delivery by CS for women who had a live birth in HF one year prior to the survey, NDHS 2022. حسب Resham B. Khatri (10949429)

Validation of distinct contribution of capsule and hypercapsule-associated HMV in IFA-conferred protection against hvKP infection using a <i>ΔrmpD</i>-K7 mutant. حسب Tingting Wang (123983)

IFA sensitized hypervirulent <i>K</i>. <i>pneumoniae</i> to complement-mediated killing by inhibiting capsule. حسب Tingting Wang (123983)

GLM models for predictors of monthly HIV costs. حسب Drew B. Cameron (10687420)

"…<div><p>Background</p><p>Despite improvements to the cascade of HIV care in East Africa, access to care for non-communicable disease co-morbidities like hypertension (HTN) remains a persistent problem. The integration of care for these conditions presents an opportunity to achieve efficiencies in delivery as well as decrease overall costs for patients. …"

Median cost (USD) per visit breakdown. حسب Drew B. Cameron (10687420)

"…<div><p>Background</p><p>Despite improvements to the cascade of HIV care in East Africa, access to care for non-communicable disease co-morbidities like hypertension (HTN) remains a persistent problem. The integration of care for these conditions presents an opportunity to achieve efficiencies in delivery as well as decrease overall costs for patients. …"

Inhibition of ferroptosis alleviated cell viability induced by <i>C. sinensis</i> ESPs. حسب Haoyang Zhang (1706815)

Inhibition of ferroptosis mitigated liver injury caused by <i>C. sinensis</i> infection. حسب Haoyang Zhang (1706815)

(a) Absolute error of the example 3, Y(x,y) for scale level ranging from 2 to 7. حسب Lahoucine Tadoummant (21647670)

(a) Absolute error of the example 3, X(x,y) for scale level ranging from 2 to 7. حسب Lahoucine Tadoummant (21647670)

Line graph showing the values of inflammatory cytokines at baseline and after treatment. حسب Káryta Suely Macêdo Martins (22404155)

Clinical and Demographic Characteristics of the Study Population. حسب Káryta Suely Macêdo Martins (22404155)

Baseline and post-treatment results of categorical electrocardiographic variables in each study group. حسب Káryta Suely Macêdo Martins (22404155)

Baseline and post-treatment results of quantitative electrocardiographic variables in each study group. حسب Káryta Suely Macêdo Martins (22404155)

CONSORT diagram illustrating patient flow during the study. حسب Káryta Suely Macêdo Martins (22404155)

Baseline and Post-Treatment Results of Echocardiographic Variables in Each Experimental Group. حسب Káryta Suely Macêdo Martins (22404155)

Baseline and Post-Treatment Serum Cytokine Levels in Each Investigational Group. حسب Káryta Suely Macêdo Martins (22404155)

Baseline and Post-Treatment Serum Levels of NT-proBNP in Each Investigational Group. حسب Káryta Suely Macêdo Martins (22404155)

Variables obtained from the SF-36 quality of life questionnaire in each experimental group. حسب Káryta Suely Macêdo Martins (22404155)

Line graph showing the values of myocardial perfusion defects in the study groups. p = ANOVA Mixed Models. حسب Káryta Suely Macêdo Martins (22404155)